The analysis estimates that in 2018, healthcare spending grew at a rate of 4.6% to $3.6 trillion, or $11,172 per person, faster than 2017’s 4.2% but equal to the 2016 rate.
The reinstatement of the health insurance tax (HIT) in 2018 was a driving factor in the increase of US healthcare spending that year, which otherwise was fairly stable, according to a report released Thursday by the Office of the Actuary at CMS.
In addition, for the second year in a row, the number of uninsured people increased by 1.0 million, reaching 30.7 million in 2018.
The tax was suspended by Congress is 2017 and 2019 but is set to resume January 1, 2020, unless Congress decides to suspend or end it. The tax was instituted as part of the Affordable Care Act.
The analysis, published by Health Affairs, estimates that in 2018, healthcare spending grew at a rate of 4.6% to $3.6 trillion, or $11,172 per person, faster than 2017’s 4.2% but equal to the 2016 rate. In 2018, the share of the economy devoted to healthcare spending, as measured by the gross domestic product, declined to 17.7% from 17.9% in 2017.
The net cost of health insurance rose 13.2% following growth of 4.3% in 2017, driven primarily by the HIT. The growth rate for total personal healthcare spending—expenditures for goods and services—remained the same in 2017 and 2018, at 4.1%.
“Health care spending growth picked up across all major payers in 2018 as medical prices grew faster, due in part to the reinstatement of the health insurance tax on all health insurance providers,” said Micah Hartman, a statistician in the CMS Office of the Actuary and first author of the Health Affairs article, in a statement. “However, economic growth outpaced health care spending and the share of the economy devoted to health care fell.”
The 0.4-percentage-point acceleration uptick was also driven by faster growth in private health insurance and Medicare.
On a per capita basis, national health spending grew 4% in 2018, compared with growth of 3.5% in 2017. Faster growth in medical prices more than offset slower growth in the use and intensity of healthcare goods and services.
Medical price growth increased 2.1% in 2018, compared with 1.3% in 2017, while the residual use and intensity of services increased 1.3% in 2018, slower than 1.6% growth in 2017. The rate of growth due to changes in the age and sex mix of the population remained at 0.6% in 2018.
Private health insurance reached $1.2 trillion in 2018 and accounted for 34% of total national health spending, rising 5.8%, faster than the 4.9% growth in 2017.
Enrollment in private health insurance decreased 0.8% in 2018 primarily because of declines in nonmarketplace directly purchased and employer-sponsored insurance plans. On a per-enrollee basis, private health insurance spending increased 6.7% over 2017—the highest growth rate since 7.5% in 2004—which can be attributed primarily to the net cost of private insurance.
Medicare spending reached $750.2 billion in 2018, accounting for 21% of total healthcare expenditures. Total Medicare spending increased 6.4%, following slower growth of 42% in 2017. Total Medicare enrollment growth was steady, but per-enrollee Medicare expenditures grew more rapidly, increasing 3.7% in 2018 compared with 1.6% in 2017. Fee-for-service Medicare spending accounted for 64% of overall Medicare spending in 2018, down slightly from a 66% share in 2017. Spending on Medicare Advantage accounted for 36% of total Medicare spending in 2018 and increased 11.8%, up from 9.9% growth in 2017.
Medicaid spending rose 3% to $597.4 billion, accounting for 16% of total national health expenditures, following growth of 2.6% in 2017. 2018 was influenced by faster growth in the net cost of insurance and was partially offset by a deceleration in enrollment growth and slower spending growth for Medicaid managed care goods and services. On a per-enrollee basis, Medicaid spending increased 2% compared with 1.2% growth in 2017.
By major goods and services:
Reference
Hartman M, Martin AB, Benson J, Catlin A. National health care spending in 2018: Growth driven by accelerations in Medicare and private insurance spending. Health Aff (Millwood). 2020; (39)1. doi: 10.1377/hlthaff.2019.01451.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More